62 related articles for article (PubMed ID: 6199480)
1. Vinblastine, bleomycin, and cis-platinum for the treatment of metastatic malignant melanoma. National Cancer Institute of Canada Melanoma Group.
J Clin Oncol; 1984 Feb; 2(2):131-4. PubMed ID: 6199480
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin, vinblastine, and bleomycin in the treatment of metastatic melanoma: a phase II study of the Southeastern Cancer Study Group.
Johnson DH; Presant C; Einhorn L; Bartolucci AA; Greco FA
Cancer Treat Rep; 1985; 69(7-8):821-4. PubMed ID: 2410120
[TBL] [Abstract][Full Text] [Related]
3. Randomized phase III trial of vinblastine, bleomycin, and cis-dichlorodiammine-platinum versus dacarbazine in malignant melanoma.
Luikart SD; Kennealey GT; Kirkwood JM
J Clin Oncol; 1984 Mar; 2(3):164-8. PubMed ID: 6199481
[TBL] [Abstract][Full Text] [Related]
4. Treatment of advanced malignant melanoma with vinblastine, bleomycin, and cisplatin.
Bajetta E; Rovej R; Buzzoni R; Vaglini M; Bonadonna G
Cancer Treat Rep; 1982 Jun; 66(6):1299-302. PubMed ID: 6177408
[TBL] [Abstract][Full Text] [Related]
5. Vinblastine, infusion, bleomycin, and cis-dichlorodiammine-platinum chemotherapy in metastatic melanoma.
Nathanson L; Kaufman SD; Carey RW
Cancer; 1981 Sep; 48(6):1290-4. PubMed ID: 6168365
[TBL] [Abstract][Full Text] [Related]
6. Pilot study of vinblastine and bleomycin combinations in the treatment of metastatic melanoma.
Nathanson L; Wittenberg BK
Cancer Treat Rep; 1980 Jan; 64(1):133-7. PubMed ID: 6155208
[TBL] [Abstract][Full Text] [Related]
7. Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma.
Legha SS; Ring S; Eton O; Bedikian A; Buzaid AC; Plager C; Papadopoulos N
J Clin Oncol; 1998 May; 16(5):1752-9. PubMed ID: 9586888
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of biochemotherapy for the treatment of metastatic malignant melanoma.
Gibbs P; Iannucci A; Becker M; Allen J; O'Driscoll M; McDowell K; Williams P; Rosse P; Murphy J; Gonzalez R
Melanoma Res; 2000 Apr; 10(2):171-9. PubMed ID: 10803718
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
[TBL] [Abstract][Full Text] [Related]
10. A phase II trial of vinblastine, bleomycin, and cisplatin induction followed by dacarbazine and dibromodulcitol maintenance in the treatment of metastatic melanoma. A follow-up study of twenty-two patients.
Gentile PS; Epremian BE; Seeger J; Hamm JT; Sheth SP
Am J Clin Oncol; 1988 Dec; 11(6):666-8. PubMed ID: 2461074
[TBL] [Abstract][Full Text] [Related]
11. Recombinant interferon ALFA-2A in combination with carboplatin, vinblastine, and bleomycin in the treatment of advanced malignant melanoma.
Bafaloukos D; Pavlidis N; Fountzilas G; Skarlos D; Klouvas G; Makrantonakis P; Giannakakis T; Tsavaris N; Kosmidis P
Am J Clin Oncol; 1996 Jun; 19(3):296-300. PubMed ID: 8638545
[TBL] [Abstract][Full Text] [Related]
12. A phase II study of neoadjuvant biochemotherapy for stage III melanoma.
Gibbs P; Anderson C; Pearlman N; LaClaire S; Becker M; Gatlin K; O'Driscoll M; Stephens J; Gonzalez R
Cancer; 2002 Jan; 94(2):470-6. PubMed ID: 11900232
[TBL] [Abstract][Full Text] [Related]
13. Combination cisplatin, vinblastine, and bleomycin chemotherapy (PVB) for malignant germ-cell tumors of the ovary.
Carlson RW; Sikic BI; Turbow MM; Ballon SC
J Clin Oncol; 1983 Oct; 1(10):645-51. PubMed ID: 6199468
[TBL] [Abstract][Full Text] [Related]
14. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin, vinblastine, and bleomycin combination chemotherapy in endodermal sinus tumor of the ovary.
Sessa C; Bonazzi C; Landoni F; Pecorelli S; Sartori E; Mangioni C
Obstet Gynecol; 1987 Aug; 70(2):220-4. PubMed ID: 2439966
[TBL] [Abstract][Full Text] [Related]
16. A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, temozolomide, interleukin 2, and IFN-alpha 2B in patients with metastatic melanoma.
Atkins MB; Gollob JA; Sosman JA; McDermott DF; Tutin L; Sorokin P; Parker RA; Mier JW
Clin Cancer Res; 2002 Oct; 8(10):3075-81. PubMed ID: 12374674
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy for esophageal cancer with mitoguazone, methotrexate, bleomycin, and cisplatin.
Vogl SE; Camacho F; Berenzweig M; Ruckdeschel J
Cancer Treat Rep; 1985 Jan; 69(1):21-3. PubMed ID: 2578314
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.
Bosl GJ; Geller NL; Bajorin D; Leitner SP; Yagoda A; Golbey RB; Scher H; Vogelzang NJ; Auman J; Carey R
J Clin Oncol; 1988 Aug; 6(8):1231-8. PubMed ID: 2457657
[TBL] [Abstract][Full Text] [Related]
19. [Effect of cis-diammine dichloroplatinum, vindesine sulfate combination chemotherapy for advanced esophageal carcinoma].
Akazawa S; Kitagawa H; Nakagawa T; Fujiki T; Kanda Y; Futatsuki K; Sampi K; Fujita K
Gan To Kagaku Ryoho; 1984 May; 11(5):1018-23. PubMed ID: 6539098
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of refractory malignant lymphomas with cisplatin, vinblastine, and bleomycin].
Avilés A; Díaz-Maqueo JC; Torras V
Rev Invest Clin; 1990; 42(2):99-102. PubMed ID: 1702554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
